These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20950578)

  • 21. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the skin sensitivity test required for administering equine rabies immunoglobulin?
    Sudarshan MK; Ashwath Narayana DH; Ravish HS
    Natl Med J India; 2011; 24(2):80-2. PubMed ID: 21668049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.
    Bakker AB; Python C; Kissling CJ; Pandya P; Marissen WE; Brink MF; Lagerwerf F; Worst S; van Corven E; Kostense S; Hartmann K; Weverling GJ; Uytdehaag F; Herzog C; Briggs DJ; Rupprecht CE; Grimaldi R; Goudsmit J
    Vaccine; 2008 Nov; 26(47):5922-7. PubMed ID: 18804136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive immunity in the prevention of rabies.
    Both L; Banyard AC; van Dolleweerd C; Horton DL; Ma JK; Fooks AR
    Lancet Infect Dis; 2012 May; 12(5):397-407. PubMed ID: 22541629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines.
    Quiambao BP; Dy-Tioco HZ; Dizon RM; Crisostomo ME; Teuwen DE
    Vaccine; 2009 Nov; 27(51):7162-6. PubMed ID: 19925947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of the administration of serum amd vaccine for the antirabies treatment of experimentally-infected sheep].
    Soria Baltazar R; Blancou J
    Rev Sci Tech; 1995 Sep; 14(3):691-710. PubMed ID: 8593402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New vaccines for immunization of man: new approaches towards the prevention of rabies in man.
    Sureau P
    Parassitologia; 1988; 30(1):141-8. PubMed ID: 2478948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of future rabies biologics and antiviral drugs.
    Smith TG; Wu X; Franka R; Rupprecht CE
    Adv Virus Res; 2011; 79():345-63. PubMed ID: 21601054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.
    Lang J; Simanjuntak GH; Soerjosembodo S; Koesharyono C
    Bull World Health Organ; 1998; 76(5):491-5. PubMed ID: 9868840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current perspectives on rabies postexposure prophylaxis.
    Blaise A; Gautret P
    Infect Disord Drug Targets; 2015; 15(1):13-9. PubMed ID: 25809623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus.
    Matsumoto T; Yamada K; Noguchi K; Nakajima K; Takada K; Khawplod P; Nishizono A
    Microbiol Immunol; 2010 Nov; 54(11):673-83. PubMed ID: 21044141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rabies vaccines: from the past to the 21st century.
    Kammer AR; Ertl HC
    Hybrid Hybridomics; 2002 Apr; 21(2):123-7. PubMed ID: 12031102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pre-exposure rabies vaccination using a new duck embryo vaccine].
    Bachmann G; Steffen R; Glück R; Wegmann A; Schär M
    Schweiz Med Wochenschr; 1985 Jun; 115(25):863-5. PubMed ID: 4023675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histamine level in the central nervous system in experimental rabies infection and immunization.
    Shokeir AA; Taha AM
    Z Immunitatsforsch Exp Klin Immunol; 1972 Mar; 143(2):206-8. PubMed ID: 4282798
    [No Abstract]   [Full Text] [Related]  

  • 37. New approaches to the prevention and eradication of rabies.
    Dietzschold B; Faber M; Schnell MJ
    Expert Rev Vaccines; 2003 Jun; 2(3):399-406. PubMed ID: 12903805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rabies update for travel medicine advisors.
    Wilde H; Briggs DJ; Meslin FX; Hemachudha T; Sitprija V
    Clin Infect Dis; 2003 Jul; 37(1):96-100. PubMed ID: 12830414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rabies].
    Simona R; Keller H
    Schweiz Med Wochenschr; 1980 Apr; 110(17):630-7. PubMed ID: 6994220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.